16 January 2023: Clinical Research
Usefulness of Detecting Brain-Derived Neurotrophic Factor in Intervertebral Disc Degeneration of the Lumbosacral Spine
Rafał Staszkiewicz 12ABDEF* , Dorian Gładysz 12ABDEF , Marcin Gralewski 12DEF , Kamil Bryś 2EF , Michał Garczarek 1EF , Marcin Gadzieliński 1EF , Wiesław Marcol 34E , Dawid Sobański 25B , Beniamin Oskar Grabarek 12ACDEFDOI: 10.12659/MSM.938663
Med Sci Monit 2023; 29:e938663
Table 2 Inclusion and exclusion criteria for the control group.
| Inclusion criteria | Exclusion criteria |
|---|---|
| Up to 45 years of age | Over 45 years of age |
| No signs of degeneration in the collected material during microscopic examination | Features of degeneration in the collected material during microscopic examination (Hematoxylin & eosin staining) |
| No neoplastic disease history | Neoplastic disease history |
| No inflammatory diseases: inflammation of the bone elements of the spine (osteomyelitis); inflammation of the IVD; epidural empyema; shingles; arthritis; inflammatory infiltrates of the rectum; Scheuermann’s disease; Paget’s disease | Spinal disease history |
| Inflammatory disease history |